Chronic liver disease questionnaire to manage patients with chronic liver diseases. Issue 8 (14th May 2022)

• Record Type: Journal Article
• Authors: Tajiri, Kazuto; Futsukaichi, Yuka Hayashi; Murayama, Aiko; Minemura, Masami; Takahara, Terumi; Yasuda, Ichiro
• Is Part Of: Hepatology research. Volume 52:Issue 8(2022)
• Page Start: 712
• Page End: 720
• Publication Date: 2022-05-14
• Subjects: chronic liver disease -- chronic liver disease questionnaire -- health‐related quality of life -- hepatocellular carcinoma -- patient‐reported outcome; Liver -- Diseases -- Periodicals; Liver Diseases -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1111/hepr.13774
• Languages: English
• ISSNs: 1386-6346

Abstract

Abstract: Background and Aims: Although patients with chronic liver disease (CLD) usually show few symptoms, they exhibit decreased health‐related QOL (HRQOL) with occurrence complications including hepatocellular carcinoma (HCC). Health‐related QOL is an important indicator in the management of CLD. The Chronic Liver Disease Questionnaire (CLDQ) was established as a tool for assessment of HRQOL. In this study, we evaluate its usefulness for the management of daily clinical practice. Methods: Patients ( N = 190, median age 70 years old) treated between 2016 and 2019 were registered and prospectively followed‐up with annual CLDQ. Associations of liver function and development of factors for admission or death were evaluated. Results: Of the 190 patients registered, median age 70 years old, 140 were Child‐A, 121 were Fib‐4 index >2.67 and showed 80 HCC. All 6 domains including Systemic Symptoms (SS) were negatively correlated with Child‐Pugh score more than with albumin‐bilirubin score and Fib‐4 index. A hundred four admission events and 49 deaths were found during observation period, and median event‐free survival was 34.3 months. Treatment for HCC was the most frequent cause of admission, and 37 liver‐related deaths were found. Systemic Symptoms score 2 years after registration was decreased in both HCC‐ and non‐HCC cohort. Systemic Symptoms decreased and SS < 4 might be predictive for event occurrence. Conclusions: CLDQ is useful to assess HRQOL in patients with CLD and is well correlated with liver function especially Child‐Pugh. Chronic Liver Disease Questionnaire might be useful to predict the prognosis of CLD and can be a tool of management in clinical practice.